Literature DB >> 23623386

Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia.

Massimo Bogliolo1, Beatrice Schuster, Chantal Stoepker, Burak Derkunt, Yan Su, Anja Raams, Juan P Trujillo, Jordi Minguillón, María J Ramírez, Roser Pujol, José A Casado, Rocío Baños, Paula Rio, Kerstin Knies, Sheila Zúñiga, Javier Benítez, Juan A Bueren, Nicolaas G J Jaspers, Orlando D Schärer, Johan P de Winter, Detlev Schindler, Jordi Surrallés.   

Abstract

Fanconi anemia (FA) is a rare genomic instability disorder characterized by progressive bone marrow failure and predisposition to cancer. FA-associated gene products are involved in the repair of DNA interstrand crosslinks (ICLs). Fifteen FA-associated genes have been identified, but the genetic basis in some individuals still remains unresolved. Here, we used whole-exome and Sanger sequencing on DNA of unclassified FA individuals and discovered biallelic germline mutations in ERCC4 (XPF), a structure-specific nuclease-encoding gene previously connected to xeroderma pigmentosum and segmental XFE progeroid syndrome. Genetic reversion and wild-type ERCC4 cDNA complemented the phenotype of the FA cell lines, providing genetic evidence that mutations in ERCC4 cause this FA subtype. Further biochemical and functional analysis demonstrated that the identified FA-causing ERCC4 mutations strongly disrupt the function of XPF in DNA ICL repair without severely compromising nucleotide excision repair. Our data show that depending on the type of ERCC4 mutation and the resulting balance between both DNA repair activities, individuals present with one of the three clinically distinct disorders, highlighting the multifunctional nature of the XPF endonuclease in genome stability and human disease.
Copyright © 2013 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23623386      PMCID: PMC3644630          DOI: 10.1016/j.ajhg.2013.04.002

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  24 in total

1.  The active site of the DNA repair endonuclease XPF-ERCC1 forms a highly conserved nuclease motif.

Authors:  Jacqueline H Enzlin; Orlando D Schärer
Journal:  EMBO J       Date:  2002-04-15       Impact factor: 11.598

2.  A mouse model of accelerated liver aging caused by a defect in DNA repair.

Authors:  Siobhán Q Gregg; Verónica Gutiérrez; Andria Rasile Robinson; Tyler Woodell; Atsunori Nakao; Mark A Ross; George K Michalopoulos; Lora Rigatti; Carrie E Rothermel; Irene Kamileri; George A Garinis; Donna Beer Stolz; Laura J Niedernhofer
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

Review 3.  Physiological consequences of defects in ERCC1-XPF DNA repair endonuclease.

Authors:  Siobhán Q Gregg; Andria Rasile Robinson; Laura J Niedernhofer
Journal:  DNA Repair (Amst)       Date:  2011-05-25

4.  Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence.

Authors:  G Weeda; I Donker; J de Wit; H Morreau; R Janssens; C J Vissers; A Nigg; H van Steeg; D Bootsma; J H Hoeijmakers
Journal:  Curr Biol       Date:  1997-06-01       Impact factor: 10.834

5.  Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning.

Authors:  J McWhir; J Selfridge; D J Harrison; S Squires; D W Melton
Journal:  Nat Genet       Date:  1993-11       Impact factor: 38.330

6.  On the role of FAN1 in Fanconi anemia.

Authors:  Juan P Trujillo; Leonardo B Mina; Roser Pujol; Massimo Bogliolo; Joris Andrieux; Muriel Holder; Beatrice Schuster; Detlev Schindler; Jordi Surrallés
Journal:  Blood       Date:  2012-05-18       Impact factor: 22.113

7.  SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype.

Authors:  Chantal Stoepker; Karolina Hain; Beatrice Schuster; Yvonne Hilhorst-Hofstee; Martin A Rooimans; Jurgen Steltenpool; Anneke B Oostra; Katharina Eirich; Elisabeth T Korthof; Aggie W M Nieuwint; Nicolaas G J Jaspers; Thomas Bettecken; Hans Joenje; Detlev Schindler; John Rouse; Johan P de Winter
Journal:  Nat Genet       Date:  2011-01-16       Impact factor: 38.330

8.  Growth retardation, early death, and DNA repair defects in mice deficient for the nucleotide excision repair enzyme XPF.

Authors:  Ming Tian; Reiko Shinkura; Nobuhiko Shinkura; Frederick W Alt
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

9.  Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease.

Authors:  A M Sijbers; W L de Laat; R R Ariza; M Biggerstaff; Y F Wei; J G Moggs; K C Carter; B K Shell; E Evans; M C de Jong; S Rademakers; J de Rooij; N G Jaspers; J H Hoeijmakers; R D Wood
Journal:  Cell       Date:  1996-09-06       Impact factor: 41.582

10.  Analysis of incision sites produced by human cell extracts and purified proteins during nucleotide excision repair of a 1,3-intrastrand d(GpTpG)-cisplatin adduct.

Authors:  J G Moggs; K J Yarema; J M Essigmann; R D Wood
Journal:  J Biol Chem       Date:  1996-03-22       Impact factor: 5.157

View more
  155 in total

1.  Replication Protein A (RPA) deficiency activates the Fanconi anemia DNA repair pathway.

Authors:  Seok-Won Jang; Jin Ki Jung; Jung Min Kim
Journal:  Cell Cycle       Date:  2016-07-11       Impact factor: 4.534

Review 2.  Advances in the understanding of the Fanconi anemia tumor suppressor pathway.

Authors:  Anna Pickering; Jun Zhang; Jayabal Panneerselvam; Peiwen Fei
Journal:  Cancer Biol Ther       Date:  2013-09-09       Impact factor: 4.742

3.  Hypersensitivities for acetaldehyde and other agents among cancer cells null for clinically relevant Fanconi anemia genes.

Authors:  Soma Ghosh; Surojit Sur; Sashidhar R Yerram; Carlo Rago; Anil K Bhunia; M Zulfiquer Hossain; Bogdan C Paun; Yunzhao R Ren; Christine A Iacobuzio-Donahue; Nilofer A Azad; Scott E Kern
Journal:  Am J Pathol       Date:  2013-11-06       Impact factor: 4.307

4.  The DNA translocase FANCM/MHF promotes replication traverse of DNA interstrand crosslinks.

Authors:  Jing Huang; Shuo Liu; Marina A Bellani; Arun Kalliat Thazhathveetil; Chen Ling; Johan P de Winter; Yinsheng Wang; Weidong Wang; Michael M Seidman
Journal:  Mol Cell       Date:  2013-10-24       Impact factor: 17.970

5.  The carboxyl terminus of FANCE recruits FANCD2 to the Fanconi Anemia (FA) E3 ligase complex to promote the FA DNA repair pathway.

Authors:  David Polito; Scott Cukras; Xiaozhe Wang; Paige Spence; Lisa Moreau; Alan D D'Andrea; Younghoon Kee
Journal:  J Biol Chem       Date:  2014-01-22       Impact factor: 5.157

Review 6.  Mechanism and regulation of incisions during DNA interstrand cross-link repair.

Authors:  Jieqiong Zhang; Johannes C Walter
Journal:  DNA Repair (Amst)       Date:  2014-04-24

7.  Predisposition to hematologic malignancies in patients with xeroderma pigmentosum.

Authors:  Karolyn A Oetjen; Melissa A Levoska; Deborah Tamura; Sawa Ito; Dorothea Douglas; Sikandar G Khan; Katherine R Calvo; Kenneth H Kraemer; John J DiGiovanna
Journal:  Haematologica       Date:  2019-08-22       Impact factor: 9.941

8.  Single-stranded DNA Binding by the Helix-Hairpin-Helix Domain of XPF Protein Contributes to the Substrate Specificity of the ERCC1-XPF Protein Complex.

Authors:  Devashish Das; Maryam Faridounnia; Lidija Kovacic; Robert Kaptein; Rolf Boelens; Gert E Folkers
Journal:  J Biol Chem       Date:  2016-12-27       Impact factor: 5.157

9.  The immune receptor Trem1 cooperates with diminished DNA damage response to induce preleukemic stem cell expansion.

Authors:  W Du; S Amarachintha; A Wilson; Q Pang
Journal:  Leukemia       Date:  2016-08-29       Impact factor: 11.528

10.  The Fanconi anemia pathway has a dual function in Dickkopf-1 transcriptional repression.

Authors:  Caroline C Huard; Cédric S Tremblay; Audrey Magron; Georges Lévesque; Madeleine Carreau
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.